Hyperkeratotic eczema of the nipple and areola associated with sorafenib treatment.
David
D
Tougeron
Eva
E
Wierzbicka-Hainaut
Sophie
S
Osdoit
Carine
C
Chagneau-Derrode
Mokrane
M
Yacoub
Christine
C
Silvain
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001557:Benzenesulfonates / Q000009:adverse effects*; D001941:Breast Diseases / Q000139:chemically induced*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D004485:Eczema / Q000139:chemically induced*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives; D009558:Nipples; D010671:Phenylurea Compounds; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib